November 2012 Volume 8, Issue 11

Volume 8, Issue 11 | November 2012

November 2012

In this Issue

Tools & Technology

Drug Discovery News Placeholder Image

Life Technologies acquires Compendia Bioscience

Bioinformatics expertise completes foundation of Life Technologies’ oncology strategy
Drug Discovery News Placeholder Image

A new view for Bruker

Bruker to acquire Carestream’s preclinical in-vivo imaging business
Drug Discovery News Placeholder Image

REFS for a different kind of judgment call

GNS Healthcare, Covance to create computer models to predict drug development success
Drug Discovery News Placeholder Image

Keeping methyltransferases simple

BellBrook Labs and Reaction Biology collaborate on screening of methyltransferases for epigenetic drug discovery

Global News

Drug Discovery News Placeholder Image

Takeda goes viral

Takeda buys LigoCyte Pharmaceuticals for $60 million cash, adds norovirus vaccine to global pipeline
Drug Discovery News Placeholder Image

Generating growth with Genfar

Acquisition of Colombia-based company expands Sanofi’s Latin American presence, boosts animal health portfolio
Drug Discovery News Placeholder Image

Making renal disease a top priority

AstraZeneca to pay as much as $272.5 million plus royalties for license to Ardelyx’s NHE3 inhibitor program
Drug Discovery News Placeholder Image

Nanobodies for voltage-gated ion channels

Ablynx and Merck to develop therapeutic nanobody candidates in potential half-billion-dollar deal
Drug Discovery News Placeholder Image

A match made in MDS

Baxter, Onconova to partner on anti-cancer compound for MDS, pancreatic cancer

Diagnostics

Drug Discovery News Placeholder Image

Narrowing in on NuroPro

Amarantus, RBCC to focus on Parkinson’s diagnostic in joint venture
Drug Discovery News Placeholder Image

Two new partners for Life

Life Technologies to partner with Bristol-Myers Squibb and CollabRx for companion diagnostics development
Drug Discovery News Placeholder Image

PROOF, MRM Proteomics turn the peptides

Protein signatures could become companion diagnostics to optimize drug discovery and patient care management
Drug Discovery News Placeholder Image

A diagnostic boost to therapeutic success

ImaginAb and Lundbeck to collaborate in neurodegeneration deal revolving around central nervous system imaging with biologics

Research & Development

Drug Discovery News Placeholder Image

All for one, one for all

Ten leading pharmas form nonprofit organization dedicated to alleviating clinical trial bottlenecks
Drug Discovery News Placeholder Image

Matchmaking in the Midwest

BioSante and ANI Pharmaceutical merge in all-stock deal
Drug Discovery News Placeholder Image

Immunological inhibitor

Astellas enters into license agreement with Janssen for RA therapy
Drug Discovery News Placeholder Image

MJFF invests $5 million in Vandy-BMS Parkinson’s collaboration

Research targets the neurotransmitter glutamate
Drug Discovery News Placeholder Image

A tremendous trio

CRI, Ludwig, MedImmune to test immunotherapy combinations for treatment of cancer
Drug Discovery News Placeholder Image

Life-science companies launch rare disease research competition

Assay Depot and Rare Genomics Institute announced Oct. 15 that they have partnered with 19 life-science companies to launch the first Rare Disease Science Challenge

Omics & Systems Biology

Drug Discovery News Placeholder Image

Toward early dementia intervention

Janssen-funded public-private partnership compares Down Syndrome to Alzheimer’s disease
Drug Discovery News Placeholder Image

Innovation, visibility and survival

Complete Genomics and BGI-Shenzhen announce merger agreement
Drug Discovery News Placeholder Image

Of a giant and a gnome

Illumina acquires BlueGnome, a provider of cytogenetics and in-vitro fertilization screening solutions
Drug Discovery News Placeholder Image

Preparing to launch personalized medicine

Air Force longitudinal study aims to prepare healthcare providers for a world rife with personal genomic information
Drug Discovery News Placeholder Image

HR-TOFMS for the metabolome

LECO and Berkeley Lab partner on metabolomics research

Government Watch

Drug Discovery News Placeholder Image

Patent saga persists

ACLU and PUBPAT ask Supreme Court to disallow Myriad patents on breast cancer genes
Drug Discovery News Placeholder Image

Meningitis outbreak plagues pharma industry

Regulators want more oversight of compounding pharmacies and regulation parity with drug manufacturers
Drug Discovery News Placeholder Image

A third way for India

Supreme Court of India sets deadline for government to present national pharmaceutical pricing policy
Drug Discovery News Placeholder Image

The great debate, 21st century-style

Presidential Commission for Study of Bioethical Issues tackles privacy issues in whole-genome sequencing

Commentary

Drug Discovery News Placeholder Image

Changing dynamics in the pharma and biotech industries

Reorganization, mergers and acquisitions (M&As), consolidation and portfolio changes are being evaluated to maintain growth centers in the face of a myriad of serious challenges. Overall, companies are looking to align with areas of growth opportunity as well as new business strategy and product development paradigms.
Drug Discovery News Placeholder Image

I’m not sure about this, but …

Personalized medicine is intended to add several layers of information into the treatment decision to make it more likely that a patient will perform as desired during treatment or perhaps more accurately, that we’ll know how a patient will perform during treatment. But personalized medicine is an incredible uphill battle, as many companies and organizations have seen over the last decade.

Editor's Focus

Drug Discovery News Placeholder Image

Pharma industry awaits impact of Obama’s second term

Now that the American people have spoken—with about 120 million votes estimated to have been cast as we went to press with this issue—and reelected President Barack Obama to a second term, many of you may be asking, “How will this affect pharma?”

Special Reports

Drug Discovery News Placeholder Image

Signals in the noise (Part 1 of 2)

Informatics challenges hinder progress in personalized medicine development
Drug Discovery News Placeholder Image

Signals in the noise (Part 2 of 2)

Informatics challenges hinder progress in personalized medicine development

Feature

Drug Discovery News Placeholder Image

Discovery, ho!

American Society for Cell Biology forges path to more strongly connect basic sciences and drug discovery
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
A 3D-rendered illustration of a eukaryotic cell highlighting organelles such as the nucleus, endoplasmic reticulum, mitochondria, and cytoskeletal structures in pink and purple tones.

Shining light on the subcellular proteome

Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue